|
anti-vegf |
6 |
|
bevacizumab |
6 |
|
pterygium |
6 |
|
ranibizumab |
6 |
|
eyelids |
4 |
|
operative |
4 |
|
surgical procedures |
4 |
|
american college students |
3 |
|
cataract |
3 |
|
chinese undergraduates |
3 |
|
cross-cultural differences |
3 |
|
individualism-collectivism |
3 |
|
lens |
3 |
|
phacoemulsification |
3 |
|
spontaneous self-concept |
3 |
|
true exfoliation |
3 |
|
twenty statements test |
3 |
|
adjuvant therapy |
2 |
|
asian |
2 |
|
clinical decision making |
2 |
|
clinical effectiveness |
2 |
|
clinical outcome |
2 |
|
ectropion |
2 |
|
entropion |
2 |
|
hughes flap |
2 |
|
involutional |
2 |
|
lower lid defect |
2 |
|
neuroblastoma |
2 |
|
reconstruction |
2 |
|
vitamin d analog |
2 |
|
academies and institutes - organization and administration |
1 |
|
acute myelogenous leukemia |
1 |
|
akt |
1 |
|
apoptosis - physiology |
1 |
|
blepharoptosis - physiopathology - surgery |
1 |
|
chemicals and cas registry numbers |
1 |
|
conditioned medium |
1 |
|
dacryocystitis |
1 |
|
doxercalciferol |
1 |
|
dual-specificity phosphatase |
1 |
|
endoscopic endonasal dacryocystorhinostomy |
1 |
|
eye -- diseases -- examinations, questions, etc |
1 |
|
eye -- examination questions |
1 |
|
eye diseases -- examination questions |
1 |
|
eyelid |
1 |
|
eyelids - physiology |
1 |
|
granulocytic sarcoma |
1 |
|
hypercalcemia |
1 |
|
ischemia |
1 |
|
ischemic postconditioning |
1 |
|
mitogen-activated protein kinase |
1 |
|
mkp-1 |
1 |
|
myeloid sarcoma |
1 |
|
nasolacrimal duct obstruction |
1 |
|
ophthalmology -- examinations, questions, etc |
1 |
|
p38 |
1 |
|
post-conditioning |
1 |
|
preconditioning |
1 |
|
rat |
1 |
|
reperfusion injury - physiopathology - prevention and control |
1 |
|
retina |
1 |
|
retinal diseases - physiopathology - prevention and control |
1 |
|
retinal ischemia |
1 |
|
retinal vessels - physiology |
1 |
|
retinoblastoma |
1 |
|
serum calcium |
1 |
|
stem cells |
1 |
|
tumor inhibition |
1 |
|
vision, ocular - physiology |
1 |
|
visual acuity - physiology |
1 |
|
xenograft model |
1 |
